Subsanong, P. 2025. Efficacy of sublingual misoprostol with intravenous oxytocin for reducing blood loss after vaginal delivery in women at risk of postpartum hemorrhage: A double-blind randomized controlled trial. Journal of Medicine and Health Sciences. 32, 1 (Apr. 2025), 158–171.